Study shows surprisingly low use of COVID antiviral treatments in nursing homes

Nursing homes were a key battleground during the COVID pandemic and prioritized for distribution of PPE, vaccines, and COVID testing kits. However, new research shows that monoclonal antibodies and oral antiviral drugs were not used in these facilities as much as would be expected given the high-risk of resident populations.

Leave A Comment

Your email address will not be published. Required fields are marked *